Epidemiology and treatment of neuropathic pain: the UK primary care perspective.
about
Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trialsHerbal medicinal products or preparations for neuropathic pain and fibromyalgiaPhenytoin for neuropathic pain and fibromyalgia in adultsClonazepam for neuropathic pain and fibromyalgia in adultsTopical capsaicin (low concentration) for chronic neuropathic pain in adultsTopical capsaicin (high concentration) for chronic neuropathic pain in adultsMilnacipran for neuropathic pain and fibromyalgia in adultsDuloxetine for treating painful neuropathy, chronic pain or fibromyalgiaAmitriptyline for neuropathic pain and fibromyalgia in adultsLacosamide for neuropathic pain and fibromyalgia in adultsLacosamide for neuropathic pain and fibromyalgia in adultsGabapentin for chronic neuropathic pain and fibromyalgia in adultsValproic acid and sodium valproate for neuropathic pain and fibromyalgia in adultsLamotrigine for acute and chronic painAmitriptyline for neuropathic pain and fibromyalgia in adultsDuloxetine for treating painful neuropathy or chronic painGabapentin for chronic neuropathic pain in adultsDuloxetine for treating painful neuropathy or chronic painLamotrigine for acute and chronic painHerbal medicinal products or preparations for neuropathic pain and fibromyalgiaStructural Magnetic Resonance Imaging Can Identify Trigeminal System Abnormalities in Classical Trigeminal NeuralgiaCombined hyperactive dysfunction syndrome of the cranial nervesPrimary care incidence and treatment of four neuropathic pain conditions: a descriptive study, 2002-2005.Dose patterns in commercially insured subjects chronically exposed to opioids: a large cohort study in the United StatesTreatment considerations for elderly and frail patients with neuropathic painTherapeutic effect of Botulinum toxin-A in 88 patients with trigeminal neuralgia with 14-month follow-up.Clinical characteristics and patterns of healthcare utilization in patients with painful neuropathic disorders in UK general practice: a retrospective cohort study.The role of the blood-brain barrier in the development and treatment of migraine and other pain disorders.Changes in trends and pattern of strong opioid prescribing in primary careBotulinum toxin type A induces direct analgesic effects in chronic neuropathic pain.Therapeutic efficacy and safety of botulinum toxin type A in trigeminal neuralgia: a systematic review.Treatment of pain in children after limb-sparing surgery: an institution's 26-year experience.Trigeminal neuralgia: frequency of occurrence in different nerve branches.Optimal duration of percutaneous microballoon compression for treatment of trigeminal nerve injury.Trigeminal neuralgia and its management.Robot-guided neuronavigated rTMS as an alternative therapy for central (neuropathic) pain: Clinical experience and long-term follow-up.Capsaicin 8% patch versus oral pregabalin in patients with peripheral neuropathic pain.An observational descriptive study of the epidemiology and treatment of neuropathic pain in a UK general population.Central antinociceptive activity of peripherally applied botulinum toxin type A in lab rat model of trigeminal neuralgia.A review of the epidemiology of painful diabetic peripheral neuropathy, postherpetic neuralgia, and less commonly studied neuropathic pain conditions.
P2860
Q21261358-27E34639-85D2-4B0C-A60F-016C01559123Q24197504-C6867CD9-A949-4E7A-BC9D-DBEAE3C4914FQ24197630-5847AA9B-147A-4589-A4F0-BFEA7052453FQ24197928-770A5AA9-A4DB-4CCE-8447-D0E8DFAF593DQ24200378-4B695E72-CB0B-4056-8075-57C6579B2701Q24200709-F0764056-DEA8-44B8-874C-A4D26E146C64Q24201093-84F72A04-B70B-4B58-8D3F-D5D30C13F454Q24201220-312779B6-A951-4051-9E83-D92EF4ACB028Q24202439-84C9F359-9C47-4FC2-B619-3C332783E887Q24203727-E202BBE5-809C-4055-B897-587504F50551Q24234774-310D7DE2-60B7-4FF0-B831-E620554ECD16Q24235709-9E2D68BC-AFC4-4AC0-820C-B11BE051708EQ24235890-CA179A60-8383-4E66-B855-EB7F252D683AQ24236694-28F66C60-EB57-4B2D-9BB7-F640750E15CBQ24239869-403D626F-F803-4982-A440-BFB5E5478300Q24240634-56CDF5AE-5B68-47B9-AE99-49617E3AB0CFQ24240890-D3158925-37FA-4AB1-916F-528C9C1394C4Q24243744-012987C4-861A-495E-BAE7-616F04AEC4C6Q24245369-1291E13F-AE8F-4C69-B4F9-1B29F2B1C6CCQ26470665-B8BC7371-E9F5-4093-BE8D-C184465EB2ACQ28069311-B40C0072-4D90-47C0-8FAE-8F64BEA61DEBQ30485442-51C3BA6B-15B9-4ABD-AB76-50300B6C8487Q33332025-4204CF29-FA65-4DAF-91B5-DABAC779A1C1Q33611209-80673595-416B-404C-9F3F-23E451CE15B9Q33747265-83E934B4-72F9-40D7-B70C-4C22D158DC4FQ33828749-B7B9C80C-C2BB-4AFA-AB76-6184F994F789Q34186481-F7BE1BE4-ED0D-4562-AC68-16A02938D9ABQ34304978-1CC0A256-09CD-4AFE-A7A7-2A8E8E83DA17Q34548856-138C4406-EA2F-49F1-9149-52F2EEDC76BBQ34785937-1BA994D2-9F52-4DF0-A6B6-562822A5C517Q34960591-AB2092D8-75B9-4AB4-922A-59CECE84ACA6Q35014088-B7155F27-7ABA-45AA-A312-BB9D1C2BCBCFQ35105554-EA3A52BE-37D4-4904-BC35-FDEBAECEF8ACQ35245452-5B162172-864C-4401-9FBD-69FF6BC56EADQ35610163-2F0051DF-DDC6-4A27-9883-75094A532A92Q35893864-49246DBA-1424-4312-A368-3EDF9135EE9BQ36536768-A334DEA8-1219-4F3C-B464-5F1419984779Q36690641-799779D3-C666-4E42-A62C-AB8AA8614A84Q36788893-C0721595-0E18-4563-86A3-FDB0EB43A310Q37062479-D017094D-D4EE-4CC1-B859-D4B4587E15A8
P2860
Epidemiology and treatment of neuropathic pain: the UK primary care perspective.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Epidemiology and treatment of neuropathic pain: the UK primary care perspective.
@ast
Epidemiology and treatment of neuropathic pain: the UK primary care perspective.
@en
Epidemiology and treatment of neuropathic pain: the UK primary care perspective.
@nl
type
label
Epidemiology and treatment of neuropathic pain: the UK primary care perspective.
@ast
Epidemiology and treatment of neuropathic pain: the UK primary care perspective.
@en
Epidemiology and treatment of neuropathic pain: the UK primary care perspective.
@nl
prefLabel
Epidemiology and treatment of neuropathic pain: the UK primary care perspective.
@ast
Epidemiology and treatment of neuropathic pain: the UK primary care perspective.
@en
Epidemiology and treatment of neuropathic pain: the UK primary care perspective.
@nl
P2093
P1433
P1476
Epidemiology and treatment of neuropathic pain: the UK primary care perspective.
@en
P2093
David Parry
Dawn Carroll
Gillian C Hall
Henry J McQuay
P304
P356
10.1016/J.PAIN.2006.01.030
P407
P577
2006-03-20T00:00:00Z